Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1997-9-2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0268-3369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
91-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9232268-Cell Separation,
pubmed-meshheading:9232268-Cyclophosphamide,
pubmed-meshheading:9232268-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:9232268-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:9232268-Humans,
pubmed-meshheading:9232268-Immunosuppressive Agents
|
pubmed:year |
1997
|
pubmed:articleTitle |
Cyclophosphamide 3 g/m2 and G-CSF is an effective and safe outpatient-based PBSC mobilising regimen: a single centre experience.
|
pubmed:publicationType |
Letter
|